Bukowski RM - Search Results

1

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.

Taylor SA, Fleming T, Von Hoff DD, McCracken JD, Bukowski RM, Talley RW, Natale RB, Guy JT, Samlowski WE, Costanzi JH. Taylor SA, et al. Among authors: bukowski rm. Invest New Drugs. 1990 Feb;8(1):77-80. doi: 10.1007/BF00216928. Invest New Drugs. 1990. PMID: 2188928 Free article. Clinical Trial.

2

Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group study.

Haas CD, McCracken JD, Vaughn CB, Stephens RL, Bukowski RM, Eyre HJ. Haas CD, et al. Among authors: bukowski rm. Invest New Drugs. 1984;2(4):401-4. doi: 10.1007/BF00171593. Invest New Drugs. 1984. PMID: 6239836

3

5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study.

Budd GT, Fleming TR, Bukowski RM, McCracken JD, Rivkin SE, O'Bryan RM, Balcerzak SP, Macdonald JS. Budd GT, et al. Among authors: bukowski rm. J Clin Oncol. 1987 Feb;5(2):272-7. doi: 10.1200/JCO.1987.5.2.272. J Clin Oncol. 1987. PMID: 3543246 Clinical Trial.

4

Phase II study of chlorozotocin in islet cell carcinoma. A southwest Oncology Group study.

Bukowski RM, McCracken JD, Balcerzak SP, Fabian CJ. Bukowski RM, et al. Cancer Chemother Pharmacol. 1983;11(1):48-50. doi: 10.1007/BF00257417. Cancer Chemother Pharmacol. 1983. PMID: 6309425

5

Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study.

Bukowski RM, Fleming TR, Macdonald JS, Oishi N, Taylor SA, Baker LH. Bukowski RM, et al. Cancer. 1993 Jan 15;71(2):322-5. doi: 10.1002/1097-0142(19930115)71:2<322::aid-cncr2820710209>3.0.co;2-g. Cancer. 1993. PMID: 8422624 Clinical Trial.

6

Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study.

Crawford ED, Saiers JH, Baker LH, Costanzi JH, Bukowski RM. Crawford ED, et al. Among authors: bukowski rm. Urology. 1991 Oct;38(4):355-7. doi: 10.1016/0090-4295(91)80152-w. Urology. 1991. PMID: 1755146 Clinical Trial.

7

A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study.

Bukowski RM, Johnson KG, Peterson RF, Stephens RL, Rivkin SE, Neilan B, Costanzi JH. Bukowski RM, et al. Cancer. 1987 Dec 15;60(12):2891-5. doi: 10.1002/1097-0142(19871215)60:12<2891::aid-cncr2820601207>3.0.co;2-6. Cancer. 1987. PMID: 2960446

8

Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.

Bukowski RM, LoBuglio A, McCracken J, Pugh R. Bukowski RM, et al. Cancer Treat Rep. 1980;64(12):1387-8. Cancer Treat Rep. 1980. PMID: 7471126

9

Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.

Bukowski RM, Tangen CM, Peterson RF, Taylor SA, Rinehart JJ, Eyre HJ, Rivkin SE, Fleming TR, Macdonald JS. Bukowski RM, et al. Cancer. 1994 Mar 1;73(5):1505-8. doi: 10.1002/1097-0142(19940301)73:5<1505::aid-cncr2820730530>3.0.co;2-v. Cancer. 1994. PMID: 8111718 Clinical Trial.

10

Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study.

Bukowski RM, Tangen C, Lee R, Macdonald JS, Einstein AB Jr, Peterson R, Fleming TR. Bukowski RM, et al. J Clin Oncol. 1992 Dec;10(12):1914-8. doi: 10.1200/JCO.1992.10.12.1914. J Clin Oncol. 1992. PMID: 1333517 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters